المؤلفون: Kinney, Mara, You, Lu, Sims, Emily K., Wherrett, Diane, Schatz, Desmond, Lord, Sandra, Krischer, Jeffrey, Russell, William E., Gottlieb, Peter A., Libman, Ingrid, Buckner, Jane, DiMeglio, Linda A., Herold, Kevan C., Steck, Andrea K.

المساهمون: Pediatrics, School of Medicine

المصدر: PMC

مصطلحات موضوعية: Type 1 diabetes, Prevention, Enrollment, Recruitment, Drug clinical trials

وصف الملف: application/pdf

العلاقة: Journal of the Endocrine Society; Kinney M, You L, Sims EK, et al. Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials. J Endocr Soc. 2023;7(3):bvad003. Published 2023 Jan 11. doi:10.1210/jendso/bvad003; https://hdl.handle.net/1805/36653Test

الإتاحة: https://doi.org/10.1210/jendso/bvad003Test
https://hdl.handle.net/1805/36653Test

المؤلفون: Jacobsen, Laura M., Bocchino, Laura, Evans-Molina, Carmella, DiMeglio, Linda, Goland, Robin, Wilson, Darrell M., Atkinson, Mark A., Aye, Tandy, Russell, William E., Wentworth, John M., Boulware, David, Geyer, Susan, Sosenko, Jay M.

المساهمون: Medicine, School of Medicine

المصدر: PMC

مصطلحات موضوعية: Age, Autoantibodies, Index60, Metabolic, Type 1 diabetes

وصف الملف: application/pdf

العلاقة: Diabetologia; Jacobsen, L. M., Bocchino, L., Evans-Molina, C., DiMeglio, L., Goland, R., Wilson, D. M., Atkinson, M. A., Aye, T., Russell, W. E., Wentworth, J. M., Boulware, D., Geyer, S., & Sosenko, J. M. (2020). The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening. Diabetologia, 63(3), 588–596. https://doi.org/10.1007/s00125-019-05047-wTest; https://hdl.handle.net/1805/23286Test

الإتاحة: https://hdl.handle.net/1805/23286Test

المؤلفون: Rigby, Mark R, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Patel, Chetanbabu M, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Moran, Antoinette, Russell, William E, Pinckney, Ashley, Keyes-Elstein, Lynette, Howell, Michael, Aggarwal, Sudeepta, Lim, Noha, Phippard, Deborah, Nepom, Gerald T, McNamara, James, Ehlers, Mario R

المساهمون: Department of Pediatrics, IU School of Medicine

المصدر: PMC

مصطلحات موضوعية: Diabetes Mellitus, Type 1, blood, drug therapy, Drug Delivery Systems, methods, Immunologic Memory, drug effects, Recombinant Fusion Proteins, administration & dosage, T-Lymphocytes

وصف الملف: application/pdf

العلاقة: The lancet. Diabetes & endocrinology; Rigby, M. R., DiMeglio, L. A., Rendell, M. S., Felner, E. I., Dostou, J. M., Gitelman, S. E., … the T1DAL Study Team. (2013). Targeting effector memory T cells with alefacept in new onset type 1 diabetes: 12 month results from the T1DAL study. The Lancet. Diabetes & Endocrinology, 1(4), 284–294. http://doi.org/10.1016/S2213-8587Test(13)70111-6; https://hdl.handle.net/1805/8663Test

الإتاحة: https://hdl.handle.net/1805/8663Test